Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P W Keeling

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Digestion|January 1, 1990
Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinomaW J Maxwell, D Kelleher, J J Keating, et al.
Gut|November 1, 1994
Microalbuminuria in inflammatory bowel diseaseN Mahmud, J Stinson, M A O'Connell, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Extrapulmonary small cell gastric carcinoma. A case report and review of the literatureK J O'Byrne, A K Cherukuri, M I Khan, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2000
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseY S Ang, N Mahmud, B White, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?T G Dinan, N Mahmud, O Rathore, et al.
Lancet (London, England)|November 21, 1981
Zinc and small babiesN J Meadows, W Ruse, M F Smith, et al.
Gastroenterology|January 29, 2000
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapyR J Farrell, A Murphy, A Long, et al.
Gut|April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator GroupC M Bate, S N Booth, J P Crowe, et al.
Journal of the Royal Society of Medicine|August 1, 1986
Trial of (+)-cyanidanol-3 in patients with hepatitis B chronic liver diseaseP W Keeling, L Viola, M G Anderson, et al.
Journal of Hepatology|August 1, 1988
Is alcohol hepatotoxic in the baboon?C C Ainley, A Senapati, I M Brown, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Digestion|January 1, 1990
Enhanced secretion of prostaglandin E2 by tissue-fixed macrophages in colonic carcinomaW J Maxwell, D Kelleher, J J Keating, et al.
Gut|November 1, 1994
Microalbuminuria in inflammatory bowel diseaseN Mahmud, J Stinson, M A O'Connell, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1997
Extrapulmonary small cell gastric carcinoma. A case report and review of the literatureK J O'Byrne, A K Cherukuri, M I Khan, et al.
Alimentary Pharmacology & Therapeutics|August 10, 2000
Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel diseaseY S Ang, N Mahmud, B White, et al.
Alimentary Pharmacology & Therapeutics|September 21, 2001
A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced?T G Dinan, N Mahmud, O Rathore, et al.
Lancet (London, England)|November 21, 1981
Zinc and small babiesN J Meadows, W Ruse, M F Smith, et al.
Gastroenterology|January 29, 2000
High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapyR J Farrell, A Murphy, A Long, et al.
Gut|April 1, 1995
Omeprazole 10 mg or 20 mg once daily in the prevention of recurrence of reflux oesophagitis. Solo Investigator GroupC M Bate, S N Booth, J P Crowe, et al.
Journal of the Royal Society of Medicine|August 1, 1986
Trial of (+)-cyanidanol-3 in patients with hepatitis B chronic liver diseaseP W Keeling, L Viola, M G Anderson, et al.
Journal of Hepatology|August 1, 1988
Is alcohol hepatotoxic in the baboon?C C Ainley, A Senapati, I M Brown, et al.
Pageof 11